Orthocell Ltd. engages in the development and commercialization of cell therapies and related technologies. Its products include CelGro which is a naturally derived collagen medical device for soft tissue repair, and Antilogous Tenocyte Implantation (Ortho-ATI) for chronic, treatment resistant tendon injuries. The company was founded by Paul Anderson and Min Hao Zheng on March 21, 2006 and is headquartered in Murdoch, Australia.

Nexilis develops proprietary device products for fixation of implants in poor bone quality. Their Immediate Stabilisation System (ISS) is the application of an implantable polymeric tube around the original implant. Through the use of ultrasonic energy, the polymeric tube is moulded into the pores of the host bone, forming a strong and uniform bond with the adjacent bone. The original device is then implanted in the denser bony environment created, leading to enhanced immediate stability. Extracellular Matrix (ECM) Coating allows coating of implants with a native extracellular matrix, leading to significantly improved long-term stabilisation of implants. ​Bisphosphonates block activity of osteoclasts, i.e. cells degrading bone. Their bisphosphonate coating allows coating of any implant surface, leading to significantly improved bone mineral density and enabling long-term stabilisation of implants.

Tissue Science Laboratories Ltd. develops and markets tissue implant products. The company was founded on January 7, 1999 and is headquartered in Watford, the United Kingdom.

Consiglio Nazionale delle Ricerche is the largest public research facility in Italy. Founded in 1923, it has worked in the past as a government consultant on research and as a funding fund for university research grants. Since 1989 the CNR is a research institution, with the mission of carrying out research projects, promoting innovation and competitiveness of the national industrial system, the internationalization of the national research system, and providing technologies and solutions to emerging needs in the public and private sectors. . Objectives that are achieved through a wealth of human resources that has over 8000 employees, half of which is represented by researchers and technologists. About 4,000 young researchers are involved in post-doctoral research activities in the laboratories of the Institute, while an important contribution comes from collaborations, including international ones, with researchers from universities and companies, thus strengthening the national research system.

Kaneka Corp. engages in the manufacture and sale of chemicals, synthetic resins, and plastics. It operates through the following segments: Material Solutions, Quality of Life Solutions, Health Care Solutions, Nutrition Solutions and Others. The Material Solutions segment covers biodegradable polymers, materials that support the development of social infrastructure and mobility which includes the weight reduction and fuel efficiency improvement. The Quality of Life Solutions segment handles energy saving needs such as housing and living infrastructure, and development of Internet of things (IoT) and artificial intelligence (AI). The Health Care Solutions segment offers solutions through the fusion of devices and medicines, and develops healthcare business based on biopharmaceuticals and regenerative and cellular medicines. The Nutrition Solutions segment provides materials and supplement solutions to food production support in livestock and fishery industries. The Others segment provides agency services for property and life insurance. The company was founded on September 1, 1949 and is headquartered in Osaka, Japan.

Ed Geistlich S��hne AG F��r Chemische Industrie is a multi-national private company headquartered in Schlieren, Switzerland. The firm operates as holding company.

Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France.

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Modern Meadow is a purpose-driven company positioned at the intersection of material science and biology with a mission to be a catalyst for real-world impact on people and the planet. Modern Meadow’s proprietary Bio-Alloy and Bio-Farm technology application platforms harness the unique properties of tuned proteins to sustainably move the world away from petrochemical and animal-derived inputs without compromising on performance. These innovations can drop into any existing infrastructures for immediate scalable adoption in the materials, beauty, and other industries. Modern Meadow's close relationship with development partners and production facilities allows companies partnering with Modern Meadow to feel confident knowing our products are 100% traceable from Lab-to-Brand.

GreenBone develops a wood-derived bone implants technology to generate biomimetic – reabsorbable– load bearing implant suitable to address non-union fractures. The idea was conceived and developed by a research group of ISTEC-CNR of Faenza comprised of Andrea Ruffini, Simone Sprio and Anna Tampieri.

Geistlich Pharma AG researches, manufactures and provides pharmaceutical products, gelatine products, biomaterials and industrial glues. It offers Geistlich Bio-Oss and Geistlich Bio-Gide products. The firm specializes in biomaterials for the regeneration of bone, cartilage and tissue and develops, and manufactures medical devices. The company was founded in 1851 and is headquartered in Wolhusen, Switzerland.

Convergent Dental is a privately-owned dental equipment and technology company developing a computer-aided dental preparation system designed to offer a comfortable patient experience during dental surgeries. It is a carbon-dioxide laser for both hard and soft tissue indications that cuts quietly, finely, and faster than other laser-based systems in dentistry using patented technologies and computer system controls.

DaebongLS Co., Ltd. engages in the manufacturing and distributing of raw materials for pharmaceuticals and cosmetics. It operates through the following business divisions: Cosmetics, Pharmaceuticals, and Food Additives. The Cosmetics division supplies conditioners, emollients, emulsifiers, permanent wave, and solubilizers. The Pharmaceuticals division offers raw materials used to prevent seizures, peptic ulcer, and hypertension. The Food Additives division provides aquacals, ascorbic acids, corn starches, fish, and folic oils. The company was founded by Jong-Ho Park on July 8, 1986 and is headquartered in Incheon, South Korea.

Acro Biomedical Co. Ltd. engages in the business of developing and marketing nutritional products that promote wellness and a healthy lifestyle. Its products include cordycepin, metallothionein, marine elements, embryonic nutrients, and active compound of antodia cinnamomea. The company was founded on September 24, 2014 and is headquartered in Fishers, IN.

Manufactures industrial sewing machines for the shoe industry

Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Others segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.

FiberTech GmbH, a subsidiary of LEONI AG, is a German company located in Berlin that produces special fibers. It was acquired by LEONI AG on November 29, 2007 for $6.67 million.